Michigan Institute of Urology-Town Center

Summary

Michigan Institute of Urology-Town Center is a medical facility located in Troy, Michigan. This center is recognized for care of Prostate Cancer, Bladder Cancer, Lung Cancer, Breast Cancer, Breast cancer and other specialties. Michigan Institute of Urology-Town Center is involved with conducting 96 clinical trials across 131 conditions. There are 11 research doctors associated with this hospital, such as Dana Zakalik, Andrew A. Muskovitz, Faisal Musa, and Joseph M. Anderson.

Top PIs

Clinical Trials running at Michigan Institute of Urology-Town Center

Lung Cancer

Esophageal cancer

Breast Cancer

Bladder Cancer

Prostate Cancer

Breast cancer

Ovarian Cancer

Stomach Cancer

Colorectal Cancer

Gastric cancer

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Biomarker Screening Test

for Lung Cancer

This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.

Recruiting

1 award

N/A

3 criteria

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria